Abstract 1367: The dual selective VEGFR-FGFR kinases inhibitor E-3810 decreases tumor perfusion and inhibits tumor growth: an analysis using dynamic contrast-enhanced magnetic resonance imaging

F. Bichat,X. Tizon,P. Provent,Virginie Bari,R. Cereda,G. Camboni,E. Cavalletti

Published 2010 in Cancer Research

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2010
Venue
Cancer Research
Publication date
2010-04-15
Fields of study
Medicine
Identifiers
DOI 10.1158/1538-7445.AM10-1367
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer
2015cites this paper
The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts
2012cites this paper